chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the evening of February of 26th it felt like I was getting a head cold.  It progressed to coughing, congestion and low-grade, at which point I decided to use home COVID-19 test that came back positive. I retested the next day to make sure that it was indeed positive. I called my doctor and let them know I had tested positive for COVID-19, they called in a prescription for the Paxlovid. I started taking it immediately. Within three days I started feeling better, the brain fog was gone, the fatigue took a little longer, but it is gone now.
Pain in left uppe arm post vaccination.  States shooting pain in arm-Instructed to see PCP or Urgent Care
Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 25Feb2021 at 09:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included alendronate sodium (ALENDRONATE) and colecalciferol/calcium citrate (CALCIUM CITRATE + D3) on an unknown date for an unknown indication and unknown if ongoing. On 27Feb2021, the patient experienced sore left arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left arm was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
evening p/vax had nausea, h/a, fever 103-104 & dizziness;no rash or resp distress;
Covid-19; chills; fever; headaches; body aches; muscle aches; vomitting; diarhea; sweating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Jun2022 at 09:15 as dose 1, single (Batch/Lot number: unknown) at the age of 47 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Diclofenac, reaction(s): "Known allergies: Diclofenac", notes: Known allergies: Diclofenac. The following information was reported: PAIN (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "body aches"; CHILLS (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering"; DIARRHOEA (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "diarhea"; PYREXIA (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "fever"; HEADACHE (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "headaches"; MYALGIA (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "muscle aches"; HYPERHIDROSIS (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "sweating"; VOMITING (non-serious) with onset 03Jun2022 at 23:00, outcome "recovering", described as "vomitting"; COVID-19 (non-serious) with onset 07Jun2022, outcome "unknown". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, pyrexia, headache, pain, myalgia, vomiting, diarrhoea, hyperhidrosis.  Additional Information: Patient did not receive other vaccine in four weeks. Patient had not COVID prior vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Redness, pain, swelling, warmth at the injection site- starting 1/7/20
Information has been received from a physician's assistant concerning a 22 year old healthy female employee with an aspirin allergy and no other drug allergies and no pertinent medical history who on approximately 28-AUG-2007 was vaccinated with the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no concomitant medication. Following vaccination on approximately 30-AUG-2007 the patient developed an immediate rash on the upper extremities, nausea, lightheadedness which lasted for 2 days, then resolved. On approximately 30-AUG-2007, there was also an injection site reaction that with a 20 mm in diameter circular red and raised lesion with central induration that was tender to the touch for 5 weeks. There was no wheezing or shortness of breath reported. On 04-OCT-2007, the patient returned for a second vaccination with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) and was examined. The patient had a negative titer for M-M-R. No other labs or diagnostic studies were performed. The patient was noted to be recovering. There was no product quality complaint. Follow-up information from the reporting physician assistant indicated that the 22 year old female phlebotomist had a history of rash following immunization with a dose of diphtheria toxoid (+) tetanus toxoid in 2006, "ROS negative" was vaccinated on approximately 28-AUG-2007 with the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Illness at the time of vaccination was denied. On 28-AUG-2007 following vaccination, the patient developed multiple rashes to the upper extremities and felt nauseous and was lightheaded for 2 days. The patient was seen at clinic on 04-OCT-2007. The patient did not return for a follow-up visit. Additional information has been requested.
chills; headache; swelling of the throat; shortness of breath; fast heartbeat; This spontaneous case was reported by a non-health professional and describes the occurrence of PHARYNGEAL SWELLING (swelling of the throat), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat), CHILLS (chills) and HEADACHE (headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PHARYNGEAL SWELLING (swelling of the throat), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat), CHILLS (chills) and HEADACHE (headache). At the time of the report, DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-085455 (Patient Link).
Since vaccination date, patient reported having intermittent difficulty with forming words and increased salivation. No other complaints reported. On exam patient had slow, mumbled speech. Rest of neuro exam was normal.  Patient was sent to Emergency Department for evaluation. On follow up 02/22/2017 patient reported that symptoms had resolved with no treatment.
I started having a sensation of scratching in the mouth; took Benadryl; Next day I started having fever up to 100.4, body aches, back pain and a cough!  second day after vaccination I was still having a dry COUGH, then I developed SHORTNESS of BREATH for at least 3 hours, and felt tightness around chest and back; took Benadryl again .It helped. Third day the cough persists, the breathing improved a bit but still there is tightness in chest.
Severe chills began at 10:30 pm; then fever spiked; slept fitfully and finally got up around 2 am to get a thermometer -while in bathroom the room started spinning and I fainted or passed out. I came to on the bathroom floor and managed to crawl back to the bed. There was confusion and the inability to understand what was going on. I remained in bed until the next morning when all symptoms abated except for some fatigue.
egg shaped swelling 1" x 1 1/2" over rt deltoid, no redness, no palpable lump, non-tender, no inc temp-swelling noted 5 days p/shot given,still present & no change @ this time;ice pack applied & heat applied 2+ wk p/shot given w/o change;
when patient came in to get 2nd vaccine. asked her about the 1st shot and she said her arm got red/bruised from shoulder to elbow. this lasted about a month and it was sore for about a week. patient never went to md or reported to pharmacy
HEADACHE; HOT FLASHES; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia, and arthritis. The patient was previously treated with tramadol for drug used for unknown indication.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 09-APR-2021 13:40 for prophylactic vaccination. Concomitant medications included diphenhydramine hydrochloride/paracetamol for drug used for unknown indication.  On 09-APR-2021, the subject experienced hot flashes. On 10-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hot flashes on 10-APR-2021, and headache on 12-APR-2021. This report was non-serious.
Swelling of entire upper arm, tenderness, fever.  We continue to have a very large number of severe arm swelling and fever after the second varicella immunization, especially in older school aged children and teens.
Unexplained bruising on abdomen, arms, legs and back. Pain under ribs, both sides, knee pain, Left knee, dizzy upon standing, nausea after eating, headaches, feels like her insides  are "shivering", tired.
Initial report received on 22 October 2014 from a healthcare professional (pharmacist). A 71 year-old female patient with not reported past medical history had received on 29 August 2014 a left deltoid injection of FLUZONE HD (lot number U5015AA not a valid lot number for this product) route of administration not reported) and the same day on 29 August 2014, experienced arm pain and numbness on the whole left arm. According to the reporter, they did not find out until 16 October 2014. The patient was evaluated by primary care physician and neurology. The patient was diagnosed with a pinched nerve and is taking pain medication. Outcome was not recovered. Documents held by sender: none.
Chest pain, leg pain, blood clots, pulmonary embolism, thrombectomy, hypotension shock, life saving measures.   Heparin and Eliquis are the medications needed to thin my blood.
Inc T104R; onset in evening; mom had already given Tylenol x 2 doses; TC to PMD; advised to double Tylenol dose; PT lethargic next day per mom; no other symptoms;
ACHES; EXHAUSTED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206a21a, and expiry: 23-JUN-2021) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced aches, and exhausted. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from exhausted, and aches. This report was non-serious.
This vaccine was given subcutaneously instead of intramuscularly. The patient is complaining of a rash on the back of her arm.
Minor soreness on arm/Pain on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Minor soreness on arm/Pain on the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Minor soreness on arm/Pain on the arm). At the time of the report, PAIN IN EXTREMITY (Minor soreness on arm/Pain on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported
Aseptic meningitis - began 10/25/12 with myalgias, HA, chills, fever. (L) arm cellulitis - began 10/28/12. Admitted to hospital 10/26. LP, empiric abx, CX (-).
Information has been received from a consumer concerning her 2-year-old daughter with no pertinent medical history or allergies who on 28-MAR-2005 and 14-APR-2005 was vaccinated with a first and second dose of MMR II. There was no concomitant medication. On 14-APR-2005 the patient stopped talking and signed for 18 months. She also lost eye contact at that time. The patient was later diagnosed with autism. The patient sought unspecified medical attention. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. Upon internal review, autism was determined to be an other medically important event (OME). Additional information has been requested.
The evening after the second vaccine we noticed the child's right nipple became red and swollen. There was a lump under the nipple. Ultrasound (one week later on 12/17) revealed enlarged breast tissue, extra vascular but no obvious infection. Blood work (drawn 12/20) showed low WBC, but no other markers indicating inflammation or infection. LH and Estradiol (drawn 12/23) are considered normal, indicating this was not precocious puberty.
Pt noted to have 4cm red circular welt on both arms in area of vaccine 48 hours post shots. Pt prescribed cephalexin 250mg/5ml oral suspension to take 15ml PO BID for 7 days. Pt also prescribed Benadryl Allergy 12.5mg/5ml oral liquid to take 5ml PO TID for 5 days. Pt will be referred to Allergy/Immunology.
Case number PHEH2014US022157 is a combined initial and follow-up spontaneous report received from a pharmacist on 01 Nov 2014 and 04 Nov 2014. This case refers to a 21 year old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with an expired dose of MENVEO (batch number: A13014 and expiry date: not reported), intramuscularly on 31 Oct 2014. No adverse event was reported following this administration error (expired vaccine used).
Recieved vaccine on 1/15/21, seizure activity noted on 1/16/21 at 2pm. Transferred to hospital. Cause of seizure unclear.   Admitted to Hospital  returned to facility on 1/22/21.  Recieved 2nd COVID-19 dose with no side effects noted.
On the date of 4/15/18 resident had been eating all meals and supplements per his baseline, resident was brought to his PM meal and was noted to hold food/fluids in his mouth and made no efforts to swallow. Staff removed food from resident's mouth and provided oral care. Resident was monitored following episode for aspiration. Following episode resident is noted to have adventitious lung sounds, poor appetite, and lack of baseline response to stimuli. Diet was changed by speech therapy to pureed and honey thick liquids, resident's plan of care has been noted to be comfort cares by POA prior to event.
Patient presented to the ED and was subsequently hospitalized on 3/22/21 with upper GI bleed. This was within 6 weeks of receiving COVID vaccination.
Patient received the first dose of Shingrix vaccine series and left to go shopping in the store. About 15 minutes after, while she was checking out at the front of the store, she started feeling dizzy/faint. She was in a scooter so she did not stand up and just kept repeating that she "didn't feel good". Paramedics were called to check her out, and they cleared her to leave shortly after they got to the store.
Acute and pervasive interstitial lung disease causing hypoxia requiring hospitalization to assist with oxygen needs  of 5?10L per min  Three month hospital followed by death on 08/07/21
This was the booster shot. My mother developed a rash, hives and her eye drained and became swollen the next day.  Each day after the booster became worse. On Saturday, December 4th, 2021, she went to Urgent Care and rushed to Hospital ER. She was diagnosed with SHINGLES.
received the second dose of the vaccine subcutaneously instead of intramuscularly; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (received the second dose of the vaccine subcutaneously instead of intramuscularly) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 02-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (received the second dose of the vaccine subcutaneously instead of intramuscularly). On 02-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (received the second dose of the vaccine subcutaneously instead of intramuscularly) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   No concomitant product use was provided. Treatment information was not available.  This report refers to a case of incorrect route of product administration for mRNA-1273, with no associated AEs.; Sender's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273, with no associated AEs.
Vaccination resulted in hospitalization in subsequent days after vaccination. Per hospital report, pt LFTs rose significantly after the vaccination resulting in hospitalization.
Following the typical fever/achiness/cough reaction 24 hours after the booster shot, my asthma was triggered as sometimes happens when I get any sort of illness. My body reacts by creating far too much fluid and my lungs fill up. Today is 11/14, and I am still coughing and have a runny nose. I wonder if a smaller dose would have had less reaction? I had the fever/achy reaction after my second dose, but there was no coughing, and it cleared up in a matter of hours. I'll be taking Benadryl again today, and expect to be fine in a couple of days. I just wasn't expecting to feel ill for more than one day.
getting injection, suffered horrible outbreak/Suspected vaccination failure; neuropathy still trouble her; suffered horrible outbreak early this year; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), neuropathy (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the neuropathy was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, neuropathy and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 14-Oct-2022 Reporter's comment: The case was received from the patient's children via interactive digital. The reporter was sure, learn about shingles, but thought very hard before getting an injection.  The patient did a couple years ago, and suffered a horrible outbreak early this year.  The neuropathy still troubles the patient.  The reporter stated that personally, he/she would look to a healthy lifestyle, not pharmaceutical promises. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown demographics. Patients pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/ allergies were reported. On unknown dates, between January, 2016 and March, 2017, these patients were vaccinated with improperly stored doses of GARDASIL 9 for prophylaxis (strength, dosing details, anatomical location, lot# and expiration date were unknown). No adverse effects were reported. Time frame of temperature excursion was from January, 2016 until March, 2017 (exact hours not provided). There were no previous temperature excursions. A data logger was involved. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Additional information has been requested. Sender's Comments: US-009507513-1704USA000110: US-009507513-1704USA000112: US-009507513-1704USA000111.
Shortness of breath while speaking was noted, slight elevation in pulse rate 100-113 bpm, flushed appearance.  Employee/student was instructed to not obtain vaccines outside provider office due to reactions and adverse affects noted.   Student agreed to remain on site under observation for 30 minutes or until the end of classroom time.  Student refused to seek medical attention at the local hospital.
pt. recvd dose M-M-R II & exp. "mumps-like synd."
I had cold-like symptoms - dry throat and cough, runny nose and a fever on the first day but it went away pretty quick. It has been two weeks now and I still have it. I do feel better than at first.  OTC type stuff - Dayquil etc. I had to cancel doctor appt because they didn't want me to come in within two weeks of symptoms.
Dizziness; Nausea; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient received 1st dose of Covid vaccine last Tuesday and 4 days later he started experiencing vertigo, dizziness and nausea and was still experiencing. The patient was called because he was worried about the 2nd dose make him sicker than the 1st and was wondered if there was anything he could take to stop any possible side effects. The outcome of the events was not recovered.  No follow-up attempts were needed, information about lot/batch number could not be obtained.